ADHD Trial, Recruiting NCT05997680 Sponsor: Anne Gallagher Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT05997680
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child has been diagnosed with congenital heart disease (a heart condition present from birth) and has had or needs heart surgery
  • The child is between 4 and 6 years old
  • The child shows lower-than-average attention skills, as measured by a specific attention test called the K-CPT2, administered during a medical or virtual visit with the research team
  • A parent or caregiver is willing to take part in an 8-week parent-child yoga program and attend assessments before, after, and 6 months following the program
  • If the child currently takes ADHD medication, the parent agrees to pause it for at least 48 hours before each assessment visit

Who may not be able to join:

  • The child has a medical reason that means yoga would not be safe for them
  • The child has a confirmed diagnosis of severe developmental or intellectual delay that would make completing the study's tests too difficult
  • The child has a severe physical disability that would prevent participation in yoga sessions without special adjustments
  • The family does not speak French or English
  • The child has already been attending a regular, structured weekly yoga program for at least one month within the past year (note: parents having their own personal yoga experience is fine)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-345-4931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anne Gallagher
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
1 May 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment rate; Dropout and withdrawal rates; Adherence; Acceptability of the randomisation process; Variation in delivery of the intervention; Missing data assessment; Standard deviations of the main outcome to be evaluated in the full RCT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov